JANTOVEN



Trademark Coverage

No Class Specified

Pharmaceutical preparations, namely anticoagulants; pharmaceutical preparations for the treatment of heart conditions and coronary artery disease

Owner
Timeline
  • Jul 11
    2013
    Notice Of Acceptance Of SEC 8 & 9 E Mailed
  • Jul 11
    2013
    Registered And Renewed (First Renewal 10 Yrs)
  • Jul 11
    2013
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • Jul 11
    2013
    Case Assigned To Post Registration Paralegal
  • Jul 01
    2013
    TEAS Section 8 & 9 Received
  • Jul 25
    2012
    TEAS Change Of Correspondence Received
  • Nov 02
    2010
    Attorney Revoked And/Or Appointed
  • Nov 02
    2010
    TEAS Revoke/Appoint Attorney Received
  • Jul 10
    2010
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • Jun 22
    2010
    Case Assigned To Post Registration Paralegal
  • Jun 04
    2010
    TEAS Section 8 & 15 Received
  • Jun 29
    2004
    Registered Principal Register
  • Mar 31
    2004
    Allowed Principal Register SOU Accepted
  • Feb 18
    2004
    Statement Of Use Processing Complete
  • Jan 15
    2004
    Use Amendment Filed
  • Jan 15
    2004
    TEAS Statement Of Use Received
  • Nov 03
    2003
    Paper Received
  • Jul 22
    2003
    NOA Mailed SOU Required From Applicant
  • Apr 29
    2003
    Published For Opposition
  • Apr 09
    2003
    Notice Of Publication
  • Mar 09
    2003
    Approved For PUB Principal Register
  • Feb 26
    2003
    Assigned To Examiner